Financials Dar Al Dawa Development and Investment Co. Ltd.
Equities
DADI
JO4101211012
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 JOD | 0.00% | +0.78% | -1.52% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 22.25 | 26.5 | 28.75 | 40.25 | 37.45 | 46.2 |
Enterprise Value (EV) 1 | 65.29 | 75.12 | 68.35 | 68.83 | 62.84 | 72.66 |
P/E ratio | -5.53 x | -3.61 x | 3.31 x | 36.9 x | 16.1 x | 14.6 x |
Yield | - | - | - | - | 4.67% | - |
Capitalization / Revenue | 0.4 x | 0.48 x | 0.54 x | 0.78 x | 0.62 x | 0.62 x |
EV / Revenue | 1.19 x | 1.37 x | 1.29 x | 1.33 x | 1.04 x | 0.97 x |
EV / EBITDA | 65.2 x | 989 x | 9.38 x | 10.1 x | 7.48 x | 7.02 x |
EV / FCF | -99.5 x | -46.6 x | -111 x | 62.7 x | 20.1 x | -73 x |
FCF Yield | -1.01% | -2.15% | -0.9% | 1.6% | 4.98% | -1.37% |
Price to Book | 0.63 x | 1.13 x | 0.92 x | 0.96 x | 0.86 x | 1.01 x |
Nbr of stocks (in thousands) | 25,000 | 25,000 | 25,000 | 35,000 | 35,000 | 35,000 |
Reference price 2 | 0.8900 | 1.060 | 1.150 | 1.150 | 1.070 | 1.320 |
Announcement Date | 19-03-31 | 20-05-18 | 21-05-11 | 22-03-31 | 23-03-31 | 24-03-31 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 55.1 | 54.86 | 53.15 | 51.77 | 60.36 | 74.88 |
EBITDA 1 | 1.002 | 0.076 | 7.287 | 6.834 | 8.397 | 10.36 |
EBIT 1 | -2.165 | -3.208 | 3.684 | 3.375 | 4.878 | 6.96 |
Operating Margin | -3.93% | -5.85% | 6.93% | 6.52% | 8.08% | 9.3% |
Earnings before Tax (EBT) 1 | -5.101 | -6.981 | 8.959 | 0.9058 | 2.57 | 2.583 |
Net income 1 | -4.024 | -7.344 | 8.678 | 1.052 | 2.323 | 3.161 |
Net margin | -7.3% | -13.39% | 16.33% | 2.03% | 3.85% | 4.22% |
EPS 2 | -0.1610 | -0.2938 | 0.3470 | 0.0311 | 0.0664 | 0.0903 |
Free Cash Flow 1 | -0.6563 | -1.613 | -0.6159 | 1.099 | 3.127 | -0.9953 |
FCF margin | -1.19% | -2.94% | -1.16% | 2.12% | 5.18% | -1.33% |
FCF Conversion (EBITDA) | - | - | - | 16.08% | 37.24% | - |
FCF Conversion (Net income) | - | - | - | 104.46% | 134.61% | - |
Dividend per Share | - | - | - | - | 0.0500 | - |
Announcement Date | 19-03-31 | 20-05-18 | 21-05-11 | 22-03-31 | 23-03-31 | 24-03-31 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 43 | 48.6 | 39.6 | 28.6 | 25.4 | 26.5 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 42.97 x | 639.9 x | 5.435 x | 4.183 x | 3.023 x | 2.555 x |
Free Cash Flow 1 | -0.66 | -1.61 | -0.62 | 1.1 | 3.13 | -1 |
ROE (net income / shareholders' equity) | -10% | -26.6% | 30.3% | 2.46% | 5.1% | 6.89% |
ROA (Net income/ Total Assets) | -1.29% | -1.93% | 2.29% | 2.1% | 2.94% | 4.02% |
Assets 1 | 311.4 | 381.2 | 379.4 | 50.08 | 78.92 | 78.64 |
Book Value Per Share 2 | 1.410 | 0.9400 | 1.240 | 1.190 | 1.240 | 1.310 |
Cash Flow per Share 2 | 0.1200 | 0.0700 | 0.4200 | 0.3200 | 0.3900 | 0.3600 |
Capex 1 | 7.08 | 2.23 | 2.09 | 1.36 | 1.67 | 2.07 |
Capex / Sales | 12.84% | 4.06% | 3.92% | 2.64% | 2.76% | 2.76% |
Announcement Date | 19-03-31 | 20-05-18 | 21-05-11 | 22-03-31 | 23-03-31 | 24-03-31 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.52% | 64.19M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- DADI Stock
- Financials Dar Al Dawa Development and Investment Co. Ltd.